1 医药子行业公募基金持仓占比一览

www.swsc.com.cn西南证券研究院2026年3月2025Q4持仓分析医药持仓环比略降低，医药主动基金加仓医疗研发外包、减仓化学制剂分析师：杜向阳执业证号：S1250520030002电话：021-68416017联系人：张旭安电话：15281061810从公募基金持仓来看2025Q4医药总持仓变化情况：25Q4全部公募基金占比7.97%，环比-1.71pp；剔除主动医药基金占比5.18%，环比-1.38pp；再剔除指数基金医药持仓占比3.33%，环比-1.51pp；申万医药板块市值占比为5.67%，环比-2.17pp。从公募基金持仓家数来看，公募基金数量前五的分别是恒瑞医药（507家）、药明康德（448家）、迈瑞医疗（204家） 、信达生物（202家）、百济神州-U（162家） 。从公募基金持仓占比情况来看，1）持仓占流通股比例前五分别为：海思科（25.0%）、百利天恒（24.9%）、热景生物（19.8%）、泽璟制药-U（18.8%）、三生制药（15.8%） ；2）持仓总股本占比前五分别为：热景生物（19.8%）、泽璟制药-U（18.8%）、三生制药（15.8%）、信达生物（12.7%）、泰格医药（12.2%）、。从公募基金持仓总市值来看，持仓总市值排名前五分别是：恒瑞医药（320亿元）、药明康德（306亿元）、信达生物（167亿元）、迈瑞医疗（152亿元）、康方生物（108亿元）；变动情况来看，基金持仓市值增加前五分别为：泰格医药（+15.9亿元）、映恩生物-B（+13.6亿元）、翰森制药（+12.2亿元）、华东医药（+11.3亿元）、康哲药业（+11.0亿元）。数据来源：Wind，西南证券整理从医药子行业持仓市值占比变化来看2025Q4医药基金医药子行业重仓市值占比变化情况：环比增加前三：医疗研发外包占比9.62%，环比增加最大，+0.46pp；医院占比0.4%，环比+0.14pp；医疗设备占比1.57%，环比+0.14pp。环比变化后三：化学制剂占比27.83%，环比变化-0.92pp；其他生物制品占比13.69%，环比-0.58pp；原料药占比1.31%，环比-0.25pp。2025Q4非医药基金医药子行业重仓市值占比变化情况：环比变化前三：原料药占比0.05%，环比增加最大，+0.00pp；医院占比0.03%，环比0.00pp；医药流通占比0.01%，环比0.00pp。环比变化后三：化学制剂占比0.36%，环比-0.30pp；其他生物制品占比0.33%，环比-0.27pp；医疗设备占比0.19%，环比-0.08pp。数据来源：Wind，西南证券整理从陆股通持仓来看2025Q4外资持股占比显著下降：25Q4沪深港通持有医药生物板块的总市值占比为2.07%，环比下降0.34pp，持股总市值为1435.02亿元，较期初下降404.4亿元。从持仓占比情况来看，1）流通股持仓占比前五分别为：理邦仪器（12.6%）、百普赛斯（10.6%）、益丰药房（10.5%）、泰格医药（9.6%）、大参林（8.2%）；流通股持仓占比增幅前五分别为：理邦仪器（+2.6pp）、奥美医疗（+2.4pp）、特一药业（+2.2pp）、惠泰医疗（+1.8pp）、新产业（+1.8pp）。2）总股本持仓占比前五分别为：益丰药房（10.5%）、大参林（8.2%）、迈瑞医疗（8%）、百普赛斯（8%）、金域医学（7.5%）；总股本持仓占比增幅前五分别为：白云山（+0.9pp）、舒泰神（+0.9pp）、科兴制药（+0.8pp）、新诺威（+0.8pp）、康弘药业（+0.7pp）。从持仓市值情况来看前五分别为：恒瑞医药（273亿元）、迈瑞医疗（185亿元）、药明康德（178亿元）、泰格医药（31亿元）、云南白药（28亿元）；持仓市值增幅前五分别为：白云山（+3.8亿元）、新产业（+3.8亿元）、泰格医药（+2.7亿元）、大参林（+2.4亿元）、新诺威（+2.2亿元）。风险提示：公募基金持仓分析是基于wind基金数据库内开放式和封闭式公募基金披露的2025Q4季报重仓持股明细汇总，存在因为部分股票在十大重仓股之外导致的样本误差风险。数据来源：Wind，西南证券整理1 医药行业公募基金持仓及外资持股占比一览近年来基金持仓总量占比情况近年来基金持仓总量占比情况外资持股变化（陆股通）外资持股变化（陆股通）2025Q4医药总持仓变化情况：25Q4全部公募基金占比7.97%，环比-1.71pp；剔除主动医药基金占比5.18%，环比-1.38pp；再剔除指数基金医药持仓占比3.33%，环比-1.51pp；申万医药板块市值占比为5.67%，环比-2.17pp。2025Q4外资持股占比显著下降：25Q4沪深港通持有医药生物板块的总市值占比为2.07%，环比下降0.34pp，持股总市值为1435.02亿元，较期初下降404.4亿元。数据来源：Wind，西南证券整理1,0001,5002,0002,5003,0003,5002021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q4持股市值（亿元）0%2%4%6%8%10%12%14%16%18%20%2014Q12014Q42015Q32016Q22017Q12017Q42018Q32019Q22020Q12020Q42021Q32022Q22023Q12023Q42024Q32025Q2扣除主动医药基金扣除主动医药基金及所有指数基金申万医药股总市值占比1 医药行业公募基金持仓及外资持股占比一览数据来源：Wind，西南证券整理2024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q4A股医药全部公募基金占比11.13%10.16%9.79%8.85%9.23%9.89%9.67%7.97%扣除主动医药基金占比7.37%6.50%6.62%6.06%6.35%7.29%6.56%5.18%扣除主动医药基金及指数基金医药持仓占比5.60%4.96%5.57%4.66%5.43%4.21%4.85%3.33%申万医药股总市值（亿元）6129055618650615995662411661967627169717A股总市值（亿元）8816885028997059498892599821310481869738581230411申万医药股总市值占比6.96%6.54%6.70%6.06%6.25%6.32%7.83%5.67%主动医药基金持有医药市值（亿元）（前十大）主动医药基金中前十大重仓医药标的占比（备注：前十大重仓医药公司市值/合计医药基金规模）32.40%31.80%31.20%26.60%26.40%28.25%31.81%30.38%指数基金医药持仓市值（亿元）（前十大）主动医药基金规模（亿元）医药指数基金规模（亿元）合计医药基金规模（亿元）
1 医药子行业公募基金持仓占比一览
数据来源：Wind，西南证券整理2025Q4 医药基金医药子行业重仓市值占比概况2025Q4医药基金医药子行业重仓市值占比概况2025Q4医药基金医药子行业重仓市值占比变化情况：环比增加前三：医疗研发外包占比9.62%，环比增加最大，+0.46pp；医院占比0.4%，环比+0.14pp；医疗设备占比1.57%，环比+0.14pp。环比变化后三：化学制剂占比27.83%，环比变化-0.92pp；其他生物制品占比13.69%，环比-0.58pp；原料药占比1.31%，环比-0.25pp。医药基金重仓值(亿元)板块总市值(亿元)占申万医药成分股总市值比重医疗研发外包9.62%0.46pp194.465368.917.70%医院0.40%0.14pp8.012226.963.19%医疗设备1.57%0.14pp31.846422.569.21%体外诊断1.21%0.08pp24.512744.603.94%中药Ⅲ0.44%0.04pp8.878621.3512.37%血液制品0.00%0.00pp0.021344.141.93%疫苗0.01%0.00pp0.212397.823.44%诊断服务0.00%-0.01pp0.07--线下药店0.23%-0.02pp4.61844.201.21%医药流通0.05%-0.04pp0.922519.463.61%医疗耗材1.40%-0.17pp28.354256.796.11%原料药1.31%-0.25pp26.483392.094.87%其他生物制品13.69%-0.58pp276.824251.966.10%化学制剂27.83%-0.92pp562.7218224.8226.14%互联网药店0.10%-1.96---5.0%0.0%5.0%10.0%15.0%20.0%25.0%30.0%35.0%化学制剂医疗研发外包医疗设备中药Ⅲ其他生物制品医疗耗材体外诊断医院血液制品医药流通原料药线下药店
1 医药子行业公募基金持仓占比一览
数据来源：Wind，西南证券整理2025Q4 医药基金医药子行业重仓市值占比概况2025Q4医药基金医药子行业重仓市值占比概况2025Q4医药基金医药子行业重仓市值占比变化情况：持仓占比前三：化学制剂27.83%，其他生物制品13.69%，医疗研发外包9.62%。25Q425Q325Q225Q124Q424Q324Q224Q1化学制剂27.83%28.75%29.48%24.77%20.00%19.37%17.07%14.97%医疗研发外包9.62%9.16%7.50%10.97%10.40%8.66%6.46%6.11%医疗设备1.57%1.44%1.61%2.80%3.70%5.19%6.39%5.65%中药Ⅲ0.44%0.40%0.66%2.48%5.50%5.11%7.34%6.96%其他生物制品13.69%14.27%10.84%7.12%4.70%3.97%3.21%3.80%医疗耗材1.40%1.57%1.56%2.70%3.10%2.69%2.59%2.55%体外诊断1.21%1.13%1.40%0.85%1.10%1.78%1.38%1.63%医院0.40%0.26%0.41%1.30%1.10%1.59%1.43%2.64%血液制品0.00%0.00%0.05%0.04%0.30%0.67%1.27%0.88%医药流通0.05%0.08%0.09%0.09%0.30%0.58%0.76%0.95%原料药1.31%1.56%2.78%2.00%1.10%0.52%0.61%0.37%线下药店0.23%0.24%0.33%0.46%0.50%0.45%0.64%1.11%疫苗0.01%0.01%0.00%0.00%0.00%0.28%0.34%0.87%诊断服务0.00%0.01%0.12%0.02%0.00%0.18%0.17%-
1 医药子行业公募基金持仓占比一览
数据来源：Wind，西南证券整理2025Q4 非医药基金医药子行业重仓市值占比概况2025Q4非医药基金医药子行业重仓市值占比概况2025Q4非医药基金医药子行业重仓市值占比变化情况：环比变化前三：原料药占比0.05%，环比增加最大，+0.00pp；医院占比0.03%，环比0.00pp；医药流通占比0.01%，环比0.00pp。环比变化后三：化学制剂占比0.36%，环比-0.30pp；其他生物制品占比0.33%，环比-0.27pp；医疗设备占比0.19%，环比-0.08pp。-0.2%0.0%0.2%0.4%0.6%0.8%1.0%1.2%1.4%1.6%化学制剂医疗设备医疗耗材中药Ⅲ医疗研发外包医院体外诊断血液制品其他生物制品原料药诊断服务医药流通医药基金重仓值(亿元)板块总市值(亿元)占申万医药成分股总市值比重原料药0.05%0.00pp16.863392.094.87%医院0.03%0.00pp12.522226.963.19%医药流通0.01%0.00pp3.772519.463.61%血液制品0.00%0.00pp0.031344.141.93%疫苗0.00%0.00pp0.712397.823.44%诊断服务0.00%-0.00pp1.310.000.00%线下药店0.01%-0.00pp4.04844.201.21%中药Ⅲ0.06%-0.00pp23.568621.3512.37%体外诊断0.06%-0.00pp22.752744.603.94%医疗耗材0.15%-0.02pp54.724256.796.11%医疗研发外包0.29%-0.07pp110.235368.917.70%医疗设备0.19%-0.08pp70.326422.569.21%其他生物制品0.33%-0.27pp124.234251.966.10%化学制剂0.36%-0.30pp136.7118224.8226.14%互联网药店0.07%-24.95--其他医疗服务0.00%-0.03--
1 医药子行业公募基金持仓占比一览
数据来源：Wind，西南证券整理2025Q4 非医药基金医药子行业重仓市值占比概况2025Q4非医药基金医药子行业重仓市值占比概况2025Q4非医药基金医药子行业重仓市值占比变化情况：持仓占比前三：化学制剂0.36%，其他生物制品0.33%，医疗研发外包0.29%。25Q425Q325Q225Q124Q424Q324Q224Q1化学制剂0.36%0.7%1.40%0.63%0.56%0.59%0.61%0.69%医疗设备0.19%0.26%1.01%0.37%0.46%0.56%0.69%0.64%医疗耗材0.15%0.17%0.19%0.19%0.23%0.23%0.22%0.23%中药III0.06%0.06%0.23%0.15%0.21%0.23%0.27%0.23%医疗研发外包0.29%0.37%0.39%0.27%0.20%0.21%0.15%0.15%医院0.03%0.03%0.08%0.07%0.05%0.09%0.09%0.11%体外诊断0.06%0.06%0.09%0.07%0.09%0.08%0.10%0.12%血液制品0.00%0.00%0.02%0.03%0.03%0.06%0.08%0.08%其他生物制品0.33%0.60%0.54%0.30%0.15%0.05%0.12%0.23%原料药0.05%0.04%0.08%0.04%0.04%0.05%0.05%0.03%诊断服务0.00%0.00%0.00%0.01%0.01%0.05%0.04%0.10%医药流通0.01%0.01%0.03%0.03%0.04%0.05%0.07%0.05%线下药店0.01%0.01%0.03%0.02%0.02%0.03%0.03%0.05%疫苗0.00%0.00%0.01%0.00%0.00%0.02%0.01%0.04%
2 医药公司持股基金数量分析
25Q4 持股基金数量TOP2025Q4持股基金数量TOP20数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅600276.SH恒瑞医药-238320.0-106.88.1%-0.9pp8.1%-0.9pp-13.9%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-13.9%300760.SZ迈瑞医疗-45151.6-47.16.6%-0.1pp6.6%-0.1pp-19.8%1801.HK信达生物-95166.5-50.312.7%-0.4pp12.7%-0.4pp-18.5%688235.SH百济神州-U-1380.6-13.21.9%0.0pp1.9%0.0pp-10.8%1530.HK三生制药-6597.0-25.615.8%-1.0pp15.8%-1.0pp-19.8%688506.SH百利天恒82.9-18.824.9%-1.4pp6.2%-0.3pp-11.0%688271.SH联影医疗-6102.1-15.09.9%0.5pp9.9%0.5pp-15.1%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.4%9926.HK康方生物-36108.0-27.310.4%0.0pp10.4%0.0pp-16.2%6990.HK科伦博泰生物-B-1284.7-18.19.3%0.7pp9.3%0.7pp-20.9%300677.SZ英科医疗-226.74.214.8%1.6pp10.5%1.1pp6.7%300759.SZ康龙化成-2459.4-9.412.1%1.0pp11.7%0.9pp-18.4%6160.HK百济神州-196.5-16.23.5%-0.1pp3.5%-0.1pp-8.5%688266.SH泽璟制药-U-4146.1-11.218.8%-0.4pp18.8%-0.4pp-14.3%688382.SH益方生物-U-1616.8-2.714.8%-0.3pp10.7%-0.2pp-11.9%1093.HK石药集团-1584.57.18.7%1.5pp8.7%1.5pp-8.2%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-19.0%2269.HK药明生物65.6-13.05.1%0.4pp5.1%0.4pp-20.6%688331.SH荣昌生物-4928.6-34.79.9%-4.7pp6.5%-3.1pp-29.3%
2 医药公司持股基金数量分析
25Q4 持股基金数量季度增加前25Q4持股基金数量季度增加前20数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅9606.HK映恩生物-B19.213.67.3%5.5pp7.3%5.5pp-16.7%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.4%603127.SH昭衍新药14.94.15.7%1.6pp5.7%1.6pp-0.8%600332.SH白云山3.61.80.9%0.4pp0.9%0.4pp1.0%688513.SH苑东生物8.66.17.9%5.3pp7.9%5.3pp15.5%002653.SZ海思科61.96.225.0%3.3pp10.8%1.5pp-4.5%301087.SZ可孚医疗6.04.97.0%5.5pp6.5%5.1pp14.0%301257.SZ普蕊斯4.33.511.1%8.8pp10.6%8.4pp13.8%000915.SZ华特达因1.91.72.4%2.1pp2.4%2.2pp6.8%688578.SH艾力斯16.34.63.5%1.1pp3.5%1.1pp-1.6%000534.SZ万泽股份2.21.82.0%1.5pp1.9%1.5pp44.5%603456.SH九洲药业1.51.31.0%0.8pp1.0%0.8pp-7.0%688488.SH艾迪药业3.53.15.1%4.5pp5.1%4.5pp13.5%3692.HK翰森制药47.012.22.2%0.6pp2.2%0.6pp1.8%000999.SZ华润三九6.62.51.4%0.5pp1.4%0.5pp2.4%000423.SZ东阿阿胶5.32.01.7%0.6pp1.7%0.6pp2.9%301367.SZ瑞迈特3.20.85.4%0.2pp4.2%0.9pp3.4%0867.HK康哲药业12.011.03.8%3.5pp3.8%3.5pp-6.2%600993.SH马应龙10.74.18.9%3.0pp8.8%3.0pp6.1%002737.SZ葵花药业2.22.12.5%2.5pp2.5%2.5pp-3.9%
2 医药公司持股基金数量分析
25Q4 持股基金数量季度减少前25Q4持股基金数量季度减少前20数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅600276.SH恒瑞医药-238320.0-106.88.1%-0.9pp8.1%-0.9pp-13.9%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-13.9%1801.HK信达生物-95166.5-50.312.7%-0.4pp12.7%-0.4pp-18.5%1530.HK三生制药-6597.0-25.615.8%-1.0pp15.8%-1.0pp-19.8%000661.SZ长春高新-5317.8-20.04.8%-2.5pp4.7%-2.4pp-28.2%688331.SH荣昌生物-4928.6-34.79.9%-4.7pp6.5%-3.1pp-29.3%300760.SZ迈瑞医疗-45151.6-47.16.6%-0.1pp6.6%-0.1pp-19.8%688266.SH泽璟制药-U-4146.1-11.218.8%-0.4pp18.8%-0.4pp-14.3%300723.SZ一品红-391.3-17.00.9%-6.5pp0.9%-6.0pp-41.1%9926.HK康方生物-36108.0-27.310.4%0.0pp10.4%0.0pp-16.2%1177.HK中国生物制药-3253.8-14.34.6%0.2pp4.6%0.2pp-23.3%688617.SH惠泰医疗-3131.6-19.19.2%-2.1pp9.2%-2.1pp-22.4%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-19.0%688114.SH华大智造-275.1-8.42.0%-2.7pp2.0%-2.7pp-9.3%002294.SZ信立泰-2644.7-23.28.1%-2.0pp8.1%-2.0pp-16.5%300759.SZ康龙化成-2459.4-9.412.1%1.0pp11.7%0.9pp-18.4%9969.HK诺诚健华-237.3-9.63.4%-1.8pp3.4%-1.8pp-30.5%2268.HK药明合联-2024.0-11.23.1%-0.5pp3.1%-0.5pp-19.1%688428.SH诺诚健华-U-207.4-10.92.0%-1.6pp2.0%-1.6pp-26.0%300003.SZ乐普医疗-196.1-1.82.5%-0.3pp2.1%-0.3pp-8.9%
2 医药公司按持股市值分析
25Q4 公募基金持股市值TOP20医药公司25Q4公募基金持股市值TOP20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅600276.SH恒瑞医药-238320.0-106.88.1%-0.9pp8.1%-0.9pp-13.9%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-13.9%1801.HK信达生物-95166.5-50.312.7%-0.4pp12.7%-0.4pp-18.5%300760.SZ迈瑞医疗-45151.6-47.16.6%-0.1pp6.6%-0.1pp-19.8%9926.HK康方生物-36108.0-27.310.4%0.0pp10.4%0.0pp-16.2%688271.SH联影医疗-6102.1-15.09.9%0.5pp9.9%0.5pp-15.1%1530.HK三生制药-6597.0-25.615.8%-1.0pp15.8%-1.0pp-19.8%6160.HK百济神州-196.5-16.23.5%-0.1pp3.5%-0.1pp-8.5%6990.HK科伦博泰生物-B-1284.7-18.19.3%0.7pp9.3%0.7pp-20.9%1093.HK石药集团-1584.57.18.7%1.5pp8.7%1.5pp-8.2%688506.SH百利天恒82.9-18.824.9%-1.4pp6.2%-0.3pp-11.0%688235.SH百济神州-U-1380.6-13.21.9%0.0pp1.9%0.0pp-10.8%2269.HK药明生物65.6-13.05.1%0.4pp5.1%0.4pp-20.6%002653.SZ海思科61.96.225.0%3.3pp10.8%1.5pp-4.5%6618.HK京东健康-960.2-25.63.4%-0.7pp3.4%-0.7pp-17.0%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.4%300759.SZ康龙化成-2459.4-9.412.1%1.0pp11.7%0.9pp-18.4%1177.HK中国生物制药-3253.8-14.34.6%0.2pp4.6%0.2pp-23.3%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-19.0%3692.HK翰森制药47.012.22.2%0.6pp2.2%0.6pp1.8%
2 医药公司按持股市值分析
25Q4 公募基金持股市值增加前
20 医药公司
25Q4公募基金持股市值增加前20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.4%9606.HK映恩生物-B19.213.67.3%5.5pp7.3%5.5pp-16.7%3692.HK翰森制药47.012.22.2%0.6pp2.2%0.6pp1.8%000963.SZ华东医药23.611.33.4%1.7pp3.4%1.7pp-3.7%0867.HK康哲药业12.011.03.8%3.5pp3.8%3.5pp-6.2%6855.HK亚盛医药-B10.39.95.3%5.2pp5.3%5.2pp-30.5%1093.HK石药集团-1584.57.18.7%1.5pp8.7%1.5pp-8.2%002653.SZ海思科61.96.225.0%3.3pp10.8%1.5pp-4.5%688513.SH苑东生物8.66.17.9%5.3pp7.9%5.3pp15.5%301087.SZ可孚医疗6.04.97.0%5.5pp6.5%5.1pp14.0%688578.SH艾力斯16.34.63.5%1.1pp3.5%1.1pp-1.6%300677.SZ英科医疗-226.74.214.8%1.6pp10.5%1.1pp6.7%000739.SZ普洛药业13.74.17.3%2.2pp7.3%2.2pp-1.0%603127.SH昭衍新药14.94.15.7%1.6pp5.7%1.6pp-0.8%600993.SH马应龙10.74.18.9%3.0pp8.8%3.0pp6.1%301257.SZ普蕊斯4.33.511.1%8.8pp10.6%8.4pp13.8%002223.SZ鱼跃医疗18.93.25.3%0.9pp4.9%0.9pp0.0%688488.SH艾迪药业3.53.15.1%4.5pp5.1%4.5pp13.5%300015.SZ爱尔眼科-136.22.84.2%0.7pp3.5%0.6pp-11.6%688606.SH奥泰生物3.02.55.8%5.0pp5.8%5.0pp-3.7%
2 医药公司按持股市值分析
25Q4 公募基金持股市值减少前
20 医药公司
25Q4公募基金持股市值减少前20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-13.9%600276.SH恒瑞医药-238320.0-106.88.1%-0.9pp8.1%-0.9pp-13.9%1801.HK信达生物-95166.5-50.312.7%-0.4pp12.7%-0.4pp-18.5%300760.SZ迈瑞医疗-45151.6-47.16.6%-0.1pp6.6%-0.1pp-19.8%0241.HK阿里健康-100.3-36.40.0%-3.4pp0.0%-3.4pp-22.8%688331.SH荣昌生物-4928.6-34.79.9%-4.7pp6.5%-3.1pp-29.3%9926.HK康方生物-36108.0-27.310.4%0.0pp10.4%0.0pp-16.2%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-19.0%1530.HK三生制药-6597.0-25.615.8%-1.0pp15.8%-1.0pp-19.8%6618.HK京东健康-960.2-25.63.4%-0.7pp3.4%-0.7pp-17.0%002294.SZ信立泰-2644.7-23.28.1%-2.0pp8.1%-2.0pp-16.5%000661.SZ长春高新-5317.8-20.04.8%-2.5pp4.7%-2.4pp-28.2%688617.SH惠泰医疗-3131.6-19.19.2%-2.1pp9.2%-2.1pp-22.4%688506.SH百利天恒82.9-18.824.9%-1.4pp6.2%-0.3pp-11.0%6990.HK科伦博泰生物--1284.7-18.19.3%0.7pp9.3%0.7pp-20.9%300723.SZ一品红-391.3-17.00.9%-6.5pp0.9%-6.0pp-41.1%6160.HK百济神州-196.5-16.23.5%-0.1pp3.5%-0.1pp-8.5%688271.SH联影医疗-6102.1-15.09.9%0.5pp9.9%0.5pp-15.1%1177.HK中国生物制药-3253.8-14.34.6%0.2pp4.6%0.2pp-23.3%688235.SH百济神州-U-1380.6-13.21.9%0.0pp1.9%0.0pp-10.8%
3 医药公司按公募基金持仓流通股占比分析
25Q4 公募基金持股流通股占比TOP20医药公司25Q4公募基金持股流通股占比TOP20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅002653.SZ海思科61.96.225.0%3.3pp10.8%1.5pp-5.8%688506.SH百利天恒82.9-18.824.9%-1.4pp6.2%-0.3pp-11.1%688068.SH热景生物-1229.8-3.119.8%-1.1pp19.8%-1.1pp-5.0%688266.SH泽璟制药-U-4146.1-11.218.8%-0.4pp18.8%-0.4pp-14.8%1530.HK三生制药-6597.0-25.615.8%-1.0pp15.8%-1.0pp-17.7%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.5%688382.SH益方生物-U-1616.8-2.714.8%-0.3pp10.7%-0.2pp-12.1%300677.SZ英科医疗-226.74.214.8%1.6pp10.5%1.1pp7.5%688197.SH首药控股-U3.0-0.413.5%1.8pp5.8%0.8pp-22.9%1801.HK信达生物-95166.5-50.312.7%-0.4pp12.7%-0.4pp-15.4%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-20.4%300759.SZ康龙化成-2459.4-9.412.1%1.0pp11.7%0.9pp-17.4%688658.SH悦康药业12.10.111.9%-0.1pp11.9%-0.1pp0.2%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-12.7%301257.SZ普蕊斯4.33.511.1%8.8pp10.6%8.4pp13.9%920047.BJ诺思兰德4.5-0.110.6%0.5pp6.9%0.3pp-6.7%688212.SH澳华内镜6.2-1.010.5%0.2pp10.5%0.2pp-12.9%9926.HK康方生物-36108.0-27.310.4%0.0pp10.4%0.0pp-17.5%688677.SH海泰新光5.3-0.910.3%-0.1pp10.3%-0.1pp-12.6%688331.SH荣昌生物-4928.6-34.79.9%-4.7pp6.5%-3.1pp-29.7%
3 医药公司按公募基金持仓流通股占比分析
25Q4 公募基金持股流通股占比增加前
20 医药公司
25Q4公募基金持股流通股占比增加前20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅301257.SZ普蕊斯4.33.511.1%8.8pp10.6%8.4pp13.8%9606.HK映恩生物-B19.213.67.3%5.5pp7.3%5.5pp-16.7%301087.SZ可孚医疗6.04.97.0%5.5pp6.5%5.1pp14.0%688513.SH苑东生物8.66.17.9%5.3pp7.9%5.3pp15.5%6855.HK亚盛医药-B10.39.95.3%5.2pp5.3%5.2pp-30.5%688606.SH奥泰生物3.02.55.8%5.0pp5.8%5.0pp-3.7%688488.SH艾迪药业3.53.15.1%4.5pp5.1%4.5pp13.5%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.4%688710.SH益诺思2.11.65.2%4.1pp3.4%2.6pp-5.7%0867.HK康哲药业12.011.03.8%3.5pp3.8%3.5pp-6.2%688062.SH迈威生物-U-26.61.78.5%3.5pp4.3%1.8pp-20.6%688566.SH吉贝尔2.91.94.8%3.5pp4.8%3.5pp-16.2%002653.SZ海思科61.96.225.0%3.3pp10.8%1.5pp-4.5%600993.SH马应龙10.74.18.9%3.0pp8.8%3.0pp6.1%301239.SZ普瑞眼科4.01.08.1%2.6pp8.1%2.6pp-10.3%002737.SZ葵花药业2.22.12.5%2.5pp2.5%2.5pp-3.9%301080.SZ百普赛斯3.61.35.3%2.3pp4.0%1.7pp-7.7%000739.SZ普洛药业13.74.17.3%2.2pp7.3%2.2pp-1.0%000915.SZ华特达因1.91.72.4%2.1pp2.4%2.2pp6.8%688176.SH亚虹医药-U1.11.02.1%2.1pp1.6%1.6pp8.8%
3 医药公司按公募基金持仓流通股占比分析
25Q4 公募基金持股流通股占比减少前
20 医药公司
25Q4公募基金持股流通股占比减少前20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅301363.SZ美好医疗3.9-1.34.4%-9.0pp2.9%-0.8pp-0.6%300723.SZ一品红-391.3-17.00.9%-6.5pp0.9%-6.0pp-41.1%300204.SZ舒泰神-140.7-7.80.6%-4.8pp0.6%-4.5pp-18.8%688331.SH荣昌生物-4928.6-34.79.9%-4.7pp6.5%-3.1pp-29.3%9688.HK再鼎医药-110.1-12.20.1%-4.0pp0.1%-4.0pp-45.2%0241.HK阿里健康-100.3-36.40.0%-3.4pp0.0%-3.4pp-22.8%002727.SZ一心堂-73.1-2.06.2%-3.2pp4.2%-2.2pp-7.6%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-19.0%688114.SH华大智造-275.1-8.42.0%-2.7pp2.0%-2.7pp-9.3%688050.SH爱博医疗-65.5-4.84.7%-2.6pp4.7%-2.5pp-17.2%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-13.9%000661.SZ长春高新-5317.8-20.04.8%-2.5pp4.7%-2.4pp-28.2%301263.SZ泰恩康-90.9-2.61.0%-2.4pp0.7%-1.7pp-12.6%600422.SH昆药集团-42.0-2.72.1%-2.3pp2.1%-2.3pp-10.5%300558.SZ贝达药业-71.5-7.10.7%-2.3pp0.7%-2.3pp-29.0%301033.SZ迈普医学-41.5-1.03.9%-2.3pp3.3%-1.9pp-5.8%688553.SH汇宇制药-W-131.3-1.92.1%-2.2pp1.7%-1.8pp-17.1%688617.SH惠泰医疗-3131.6-19.19.2%-2.1pp9.2%-2.1pp-22.4%002294.SZ信立泰-2644.7-23.28.1%-2.0pp8.1%-2.0pp-16.5%688581.SH安杰思-100.0-0.60.0%-1.9pp0.0%-1.0pp-18.9%
4 医药公司按公募基金持仓总股本占比分析
25Q4 公募基金持股总股本占比TOP20医药公司25Q4公募基金持股总股本占比TOP20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅688068.SH热景生物-1229.8-3.119.8%-1.1pp19.8%-1.1pp-5.0%688266.SH泽璟制药-U-4146.1-11.218.8%-0.4pp18.8%-0.4pp-14.8%1530.HK三生制药-6597.0-25.615.8%-1.0pp15.8%-1.0pp-17.7%1801.HK信达生物-95166.5-50.312.7%-0.4pp12.7%-0.4pp-15.4%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.5%688658.SH悦康药业12.10.111.9%-0.1pp11.9%-0.1pp0.2%300759.SZ康龙化成-2459.4-9.412.1%1.0pp11.7%0.9pp-17.4%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-12.7%002653.SZ海思科61.96.225.0%3.3pp10.8%1.5pp-5.8%688382.SH益方生物-U-1616.8-2.714.8%-0.3pp10.7%-0.2pp-12.1%301257.SZ普蕊斯4.33.511.1%8.8pp10.6%8.4pp13.9%688212.SH澳华内镜6.2-1.010.5%0.2pp10.5%0.2pp-12.9%300677.SZ英科医疗-226.74.214.8%1.6pp10.5%1.1pp7.5%9926.HK康方生物-36108.0-27.310.4%0.0pp10.4%0.0pp-17.5%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-20.4%688677.SH海泰新光5.3-0.910.3%-0.1pp10.3%-0.1pp-12.6%688271.SH联影医疗-6102.1-15.09.9%0.5pp9.9%0.5pp-14.0%600750.SH华润江中#N/A14.4#N/A9.9%#N/A9.8%#N/A9.4%688192.SH迪哲医药-U-1025.9-2.09.8%0.4pp9.7%1.3pp-20.9%6990.HK科伦博泰生物--1284.7-18.19.3%0.7pp9.3%0.7pp-19.5%
5 医药公司按公募基金持仓总股本占比分析
25Q4 公募基金持股总股本占比增加前
20 医药公司
25Q4公募基金持股总股本占比增加前20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅301257.SZ普蕊斯4.33.511.1%8.8pp10.6%8.4pp13.8%9606.HK映恩生物-B19.213.67.3%5.5pp7.3%5.5pp-16.7%688513.SH苑东生物8.66.17.9%5.3pp7.9%5.3pp15.5%6855.HK亚盛医药-B10.39.95.3%5.2pp5.3%5.2pp-30.5%301087.SZ可孚医疗6.04.97.0%5.5pp6.5%5.1pp14.0%688606.SH奥泰生物3.02.55.8%5.0pp5.8%5.0pp-3.7%688488.SH艾迪药业3.53.15.1%4.5pp5.1%4.5pp13.5%0867.HK康哲药业12.011.03.8%3.5pp3.8%3.5pp-6.2%688566.SH吉贝尔2.91.94.8%3.5pp4.8%3.5pp-16.2%300347.SZ泰格医药59.515.915.2%4.3pp12.2%3.5pp-3.4%600993.SH马应龙10.74.18.9%3.0pp8.8%3.0pp6.1%688710.SH益诺思2.11.65.2%4.1pp3.4%2.6pp-5.7%301239.SZ普瑞眼科4.01.08.1%2.6pp8.1%2.6pp-10.3%002737.SZ葵花药业2.22.12.5%2.5pp2.5%2.5pp-3.9%000739.SZ普洛药业13.74.17.3%2.2pp7.3%2.2pp-1.0%000915.SZ华特达因1.91.72.4%2.1pp2.4%2.2pp6.8%688062.SH迈威生物-U-26.61.78.5%3.5pp4.3%1.8pp-20.6%000963.SZ华东医药23.611.33.4%1.7pp3.4%1.7pp-3.7%301080.SZ百普赛斯3.61.35.3%2.3pp4.0%1.7pp-7.7%603127.SH昭衍新药14.94.15.7%1.6pp5.7%1.6pp-0.8%
5 医药公司按公募基金持仓总股本占比分析
25Q4 公募基金持股总股本占比减少前
20 医药公司
25Q4公募基金持股总股本占比减少前20医药公司数据来源：Wind，西南证券整理，市值数据截至2025.12.31代码名称持股基金数量持股总市值(亿元)流通股本占比总股本占比季度最新市值（亿元）最新季度变化最新季度变化最新季度变化最新季度变化涨跌幅300723.SZ一品红-391.3-17.00.9%-6.5pp0.9%-6.0pp-41.1%300204.SZ舒泰神-140.7-7.80.6%-4.8pp0.6%-4.5pp-18.8%9688.HK再鼎医药-110.1-12.20.1%-4.0pp0.1%-4.0pp-45.2%0241.HK阿里健康-100.3-36.40.0%-3.4pp0.0%-3.4pp-22.8%688331.SH荣昌生物-4928.6-34.79.9%-4.7pp6.5%-3.1pp-29.3%688114.SH华大智造-275.1-8.42.0%-2.7pp2.0%-2.7pp-9.3%603259.SH药明康德-160306.1-154.611.3%-2.5pp11.3%-2.6pp-13.9%002422.SZ科伦药业-2948.3-26.912.6%-3.1pp10.3%-2.5pp-19.0%688050.SH爱博医疗-65.5-4.84.7%-2.6pp4.7%-2.5pp-17.2%000661.SZ长春高新-5317.8-20.04.8%-2.5pp4.7%-2.4pp-28.2%600422.SH昆药集团-42.0-2.72.1%-2.3pp2.1%-2.3pp-10.5%300558.SZ贝达药业-71.5-7.10.7%-2.3pp0.7%-2.3pp-29.0%002727.SZ一心堂-73.1-2.06.2%-3.2pp4.2%-2.2pp-7.6%688617.SH惠泰医疗-3131.6-19.19.2%-2.1pp9.2%-2.1pp-22.4%002294.SZ信立泰-2644.7-23.28.1%-2.0pp8.1%-2.0pp-16.5%301033.SZ迈普医学-41.5-1.03.9%-2.3pp3.3%-1.9pp-5.8%2162.HK康诺亚-B-130.8-4.50.5%-1.9pp0.5%-1.9pp-27.8%603520.SH司太立-20.6-1.01.3%-1.8pp1.3%-1.8pp-13.2%9969.HK诺诚健华-237.3-9.63.4%-1.8pp3.4%-1.8pp-30.5%688553.SH汇宇制药-W-131.3-1.92.1%-2.2pp1.7%-1.8pp-17.1%
6 陆股通持仓医药个股分析-流通股本占比
TOP10增加前10减少前10注：陆股通个股数据区间为2025/9/30-2025/12/31 数据来源：Wind，西南证券整理代码名称流通股本占比总股本占比持股市值（亿元）期间涨跌幅季度末季度变化季度末季度变化季度末季度变化300206.SZ理邦仪器12.59%2.58pp7.35%1.51pp5.41.47.6%301080.SZ百普赛斯10.59%-0.11pp7.98%-0.09pp7.2-0.9-7.7%603939.SH益丰药房10.47%-5.96pp10.47%-5.96pp27.6-21.5-11.7%300347.SZ泰格医药9.56%1.02pp6.29%0.67pp30.72.7-3.4%603233.SH大参林8.20%0.74pp8.20%0.74pp16.42.47.4%300760.SZ迈瑞医疗8.03%-1.59pp8.03%-1.59pp185.4-101.3-19.8%603259.SH药明康德7.94%-2.12pp6.58%-1.81pp178.0-100.9-13.9%603882.SH金域医学7.53%-0.18pp7.48%-0.18pp9.8-0.7-3.3%600276.SH恒瑞医药7.19%-0.44pp6.91%-0.43pp273.2-75.2-13.9%688617.SH惠泰医疗6.42%1.84pp6.42%1.84pp22.01.6-22.4%300206.SZ理邦仪器12.59%2.58pp7.35%1.51pp5.41.47.6%002950.SZ奥美医疗6.35%2.38pp4.53%1.70pp3.11.415.7%002728.SZ特一药业2.59%2.22pp1.90%1.63pp1.10.927.3%688617.SH惠泰医疗6.42%1.84pp6.42%1.84pp22.01.6-22.4%300832.SZ新产业5.70%1.82pp4.95%1.58pp21.93.8-16.1%002173.SZ创新医疗1.34%1.34pp1.26%1.26pp1.21.24.7%688062.SH迈威生物-U2.72%1.31pp1.39%0.67pp2.10.7-20.6%301507.SZ民生健康2.20%1.27pp0.68%0.39pp0.40.211.4%688046.SH药康生物1.66%1.11pp1.66%1.11pp1.00.6-12.9%301246.SZ宏源药业1.78%1.09pp0.71%0.44pp0.70.671.7%603939.SH益丰药房10.47%-5.96pp10.47%-5.96pp27.6-21.5-11.7%300685.SZ艾德生物5.45%-3.64pp5.42%-3.62pp4.3-3.8-9.7%300199.SZ翰宇药业1.01%-3.49pp0.85%-2.94pp1.4-5.8-14.8%688382.SH益方生物-U0.81%-3.07pp0.59%-2.22pp0.9-4.1-11.9%603259.SH药明康德7.94%-2.12pp6.58%-1.81pp178.0-100.9-13.9%300158.SZ振东制药1.69%-2.04pp1.69%-2.04pp1.0-1.5-11.6%002317.SZ众生药业1.23%-1.75pp1.10%-1.56pp1.8-2.111.8%300760.SZ迈瑞医疗8.03%-1.59pp8.03%-1.59pp185.4-101.3-19.8%301363.SZ美好医疗1.01%-1.37pp0.66%0.01pp0.9-0.0-0.6%688621.SH阳光诺和0.24%-1.36pp0.24%-1.36pp0.2-1.0-7.0%
7 陆股通持仓医药个股分析-总股本占比
TOP10增加前10减少前10代码名称流通股本占比总股本占比持股市值（亿元）期间涨跌幅季度末季度变化季度末季度变化季度末季度变化603939.SH益丰药房10.47%-5.96pp10.47%-5.96pp27.6-21.5-11.7%603233.SH大参林8.20%0.74pp8.20%0.74pp16.42.47.4%300760.SZ迈瑞医疗8.03%-1.59pp8.03%-1.59pp185.4-101.3-19.8%301080.SZ百普赛斯10.59%-0.11pp7.98%-0.09pp7.2-0.9-7.7%603882.SH金域医学7.53%-0.18pp7.48%-0.18pp9.8-0.7-3.3%300206.SZ理邦仪器12.59%2.58pp7.35%1.51pp5.41.47.6%600276.SH恒瑞医药7.19%-0.44pp6.91%-0.43pp273.2-75.2-13.9%603259.SH药明康德7.94%-2.12pp6.58%-1.81pp178.0-100.9-13.9%688617.SH惠泰医疗6.42%1.84pp6.42%1.84pp22.01.6-22.4%300347.SZ泰格医药9.56%1.02pp6.29%0.67pp30.72.7-3.4%600332.SH白云山2.47%1.05pp2.14%0.91pp8.93.81.0%300204.SZ舒泰神1.01%0.90pp0.96%0.86pp1.31.1-18.8%688136.SH科兴制药1.10%0.80pp1.10%0.80pp0.70.5-17.4%300765.SZ新诺威2.05%0.62pp2.05%0.78pp10.42.2-22.4%002773.SZ康弘药业5.07%0.99pp3.78%0.74pp10.40.1-17.8%603233.SH大参林8.20%0.74pp8.20%0.74pp16.42.47.4%300233.SZ金城医药1.61%0.72pp1.56%0.69pp0.80.2-22.5%300347.SZ泰格医药9.56%1.02pp6.29%0.67pp30.72.7-3.4%688062.SH迈威生物-U2.72%1.31pp1.39%0.67pp2.10.7-20.6%300363.SZ博腾股份5.51%0.72pp5.06%0.67pp6.40.2-5.0%688315.SH诺禾致源0.33%-0.79pp0.33%-0.79pp0.2-0.6-13.5%688161.SH威高骨科0.09%-0.77pp0.09%-0.77pp0.1-1.0-13.5%000513.SZ丽珠集团2.10%-1.13pp1.34%-0.74pp4.1-3.1-10.6%688658.SH悦康药业0.25%-0.74pp0.25%-0.74pp0.3-0.7-0.6%600812.SH华北制药0.50%-0.67pp0.50%-0.67pp0.5-0.7-4.8%000538.SZ云南白药2.77%-0.64pp2.75%-0.64pp27.9-6.4-1.0%688266.SH泽璟制药-U0.54%-0.62pp0.54%-0.62pp1.3-2.1-14.3%002007.SZ华兰生物1.23%-0.68pp1.06%-0.58pp2.9-1.8-2.2%688029.SH南微医学1.37%-0.58pp1.37%-0.58pp2.1-1.6-12.6%688016.SH心脉医疗1.50%-0.56pp1.50%-0.56pp1.7-1.1-14.3%注：陆股通个股数据区间为2025/9/30-2025/12/31 数据来源：Wind，西南证券整理
8 陆股通持仓医药个股分析-持仓市值
TOP10增加前10减少前10注：陆股通个股数据区间为2025/9/30-2025/12/31 数据来源：Wind，西南证券整理代码名称流通股本占比总股本占比持股市值（亿元）期间涨跌幅季度末季度变化季度末季度变化季度末季度变化600276.SH恒瑞医药7.19%-0.44pp6.91%-0.43pp273.2-75.2-13.9%300760.SZ迈瑞医疗8.03%-1.59pp8.03%-1.59pp185.4-101.3-19.8%603259.SH药明康德7.94%-2.12pp6.58%-1.81pp178.0-100.9-13.9%300347.SZ泰格医药9.56%1.02pp6.29%0.67pp30.72.7-3.4%000538.SZ云南白药2.77%-0.64pp2.75%-0.64pp27.9-6.4-1.0%603939.SH益丰药房10.47%-5.96pp10.47%-5.96pp27.6-21.5-11.7%688271.SH联影医疗2.13%-0.18pp2.13%-0.18pp22.0-6.8-15.1%688617.SH惠泰医疗6.42%1.84pp6.42%1.84pp22.01.6-22.4%300832.SZ新产业5.70%1.82pp4.95%1.58pp21.93.8-16.1%688578.SH艾力斯4.60%-0.05pp4.60%-0.05pp21.6-1.5-1.6%600332.SH白云山2.47%1.05pp2.14%0.91pp8.93.81.0%300832.SZ新产业5.70%1.82pp4.95%1.58pp21.93.8-16.1%300347.SZ泰格医药9.56%1.02pp6.29%0.67pp30.72.7-3.4%603233.SH大参林8.20%0.74pp8.20%0.74pp16.42.47.4%300765.SZ新诺威2.05%0.62pp2.05%0.78pp10.42.2-22.4%688617.SH惠泰医疗6.42%1.84pp6.42%1.84pp22.01.6-22.4%002950.SZ奥美医疗6.35%2.38pp4.53%1.70pp3.11.415.7%300206.SZ理邦仪器12.59%2.58pp7.35%1.51pp5.41.47.6%600285.SH羚锐制药1.81%1.07pp1.80%1.07pp2.11.2-6.0%002173.SZ创新医疗1.34%1.34pp1.26%1.26pp1.21.24.7%300760.SZ迈瑞医疗8.03%-1.59pp8.03%-1.59pp185.4-101.3-19.8%603259.SH药明康德7.94%-2.12pp6.58%-1.81pp178.0-100.9-13.9%600276.SH恒瑞医药7.19%-0.44pp6.91%-0.43pp273.2-75.2-13.9%603939.SH益丰药房10.47%-5.96pp10.47%-5.96pp27.6-21.5-11.7%688271.SH联影医疗2.13%-0.18pp2.13%-0.18pp22.0-6.8-15.1%002821.SZ凯莱英2.93%-1.26pp2.58%-1.11pp8.6-6.5-15.5%000538.SZ云南白药2.77%-0.64pp2.75%-0.64pp27.9-6.4-1.0%300199.SZ翰宇药业1.01%-3.49pp0.85%-2.94pp1.4-5.8-14.8%000661.SZ长春高新2.07%-0.37pp2.03%-0.36pp7.7-5.0-28.2%600079.SH人福医药1.61%-1.12pp1.52%-1.06pp4.5-4.4-13.5%西南证券研究院